Dynamic karyotype, dynamic proteome: Buffering the effects of aneuploidy

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 2, 2014, Pages 473-481

  Donnelly, Neysan ^a   Storchová, Zuzana ^a,b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b Munich Center for Integrated Protein Science   (Germany)

Author keywords

Gene expression; Genome dynamics; Genome stability; Proteomics

Indexed keywords

MESSENGER RNA; PROTEOME;

ANEUPLOIDY; CHROMOSOME NUMBER; CORRELATIONAL STUDY; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; KARYOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; REVIEW;

GENE EXPRESSION; GENOME DYNAMICS; GENOME STABILITY; PROTEOMICS;

ANEUPLOIDY; ANIMALS; DOSAGE COMPENSATION, GENETIC; GENE DOSAGE; HUMANS; KARYOTYPE; MODELS, GENETIC; PROTEOME;

EID: 84890812878     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.11.017     Document Type: Review

References (89)

1. Thompson S.L., Bakhoum S.F., Compton D.A. Mechanisms of chromosomal instability. Curr. Biol. 2010, 20:R285-R295.
2. Colnaghi R., Carpenter G., Volker M., O'Driscoll M. The consequences of structural genomic alterations in humans: genomic disorders, genomic instability and cancer. Semin. Cell Dev. Biol. 2011, 22:875-885.
3. Stankiewicz P., Lupski J.R. Structural variation in the human genome and its role in disease. Annu. Rev. Med. 2010, 61:437-455.
4. Gordon D.J., Resio B., Pellman D. Causes and consequences of aneuploidy in cancer. Nat. Rev. Genet. 2012, 13:189-203.
5. Sheltzer J.M., Blank H.M., Pfau S.J., Tange Y., George B.M., Humpton T.J., Brito I.L., Hiraoka Y., Niwa O., Amon A. Aneuploidy drives genomic instability in yeast. Science 2011, 333:1026-1030.
6. Zhu J., Pavelka N., Bradford W.D., Rancati G., Li R. Karyotypic Determinants of Chromosome Instability in Aneuploid Budding Yeast. PLoS Genet. 2012, 8:e1002719.
7. Duesberg P., Rasnick D., Li R., Winters L., Rausch C., Hehlmann R. How aneuploidy may cause cancer and genetic instability. Anticancer Res. 1999, 19:4887-4906.
8. Weaver B.A., Cleveland D.W. Does aneuploidy cause cancer?. Curr. Opin. Cell Biol. 2006, 18:658-667.
9. Storchova Z., Kuffer C. The consequences of tetraploidy and aneuploidy. J. Cell Sci. 2008, 121:3859-3866.
10. Walther A., Houlston R., Tomlinson I. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 2008, 57:941-950.
11. McGranahan N., Burrell R.A., Endesfelder D., Novelli M.R., Swanton C. Cancer chromosomal instability: therapeutic and diagnostic challenges. EMBO Rep. 2012, 13:528-538.
12. Upender M.B., Habermann J.K., McShane L.M., Korn E.L., Barrett J.C., Difilippantonio M.J., Ried T. Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res. 2004, 64:6941-6949.
13. Niwa O., Tange Y., Kurabayashi A. Growth arrest and chromosome instability in aneuploid yeast. Yeast 2006, 23:937-950.
14. Torres E.M., Sokolsky T., Tucker C.M., Chan L.Y., Boselli M., Dunham M.J., Amon A. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 2007, 317:916-924.
15. Williams B.R., Prabhu V.R., Hunter K.E., Glazier C.M., Whittaker C.A., Housman D.E., Amon A. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 2008, 322:703-709.
16. Pavelka N., Rancati G., Zhu J., Bradford W.D., Saraf A., Florens L., Sanderson B.W., Hattem G.L., Li R. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature 2010, 468:321-325.
17. Nawata H., Kashino G., Tano K., Daino K., Shimada Y., Kugoh H., Oshimura M., Watanabe M. Dysregulation of gene expression in the artificial human trisomy cells of chromosome 8 associated with transformed cell phenotypes. PLoS ONE 2011, 6:e25319.
18. Stingele S., Stoehr G., Peplowska K., Cox J., Mann M., Storchova Z. Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol. Syst. Biol. 2012, 8:608.
19. Katz W., Weinstein B., Solomon F. Regulation of tubulin levels and microtubule assembly in Saccharomyces cerevisiae: consequences of altered tubulin gene copy number. Mol. Cell. Biol. 1990, 10:5286-5294.
20. Lindsley D.L., Sandler L., Baker B.S., Carpenter A.T., Denell R.E., Hall J.C., Jacobs P.A., Miklos G.L., Davis B.K., Gethmann R.C., Hardy R.W., Steven A.H., Miller M., Nozawa H., Parry D.M., Gould-Somero M., Gould-Somero M. Segmental aneuploidy and the genetic gross structure of the Drosophila genome. Genetics 1972, 71:157-184.
21. Sheltzer J.M., Torres E.M., Dunham M.J., Amon A. Transcriptional consequences of aneuploidy. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:12644-12649.
22. Bond U., Neal C., Donnelly D., James T.C. Aneuploidy and copy number breakpoints in the genome of lager yeasts mapped by microarray hybridisation. Curr. Genet. 2004, 45:360-370.
23. Kvitek D.J., Will J.L., Gasch A.P. Variations in stress sensitivity and genomic expression in diverse S. cerevisiae isolates. PLoS Genet. 2008, 4:e1000223.
24. Tůmová P., Hofštetrová K., Nohýnková E., Hovorka O., Král J. Cytogenetic evidence for diversity of two nuclei within a single diplomonad cell of Giardia. Chromosoma 2007, 116:65-78.
25. Minning T.A., Weatherly D.B., Flibotte S., Tarleton R.L. Widespread, focal copy number variations (CNV) and whole chromosome aneuploidies in Trypanosoma cruzi strains revealed by array comparative genomic hybridization. BMC Genomics 2011, 12:139.
26. Mannaert A., Downing T., Imamura H., Dujardin J.-C. Adaptive mechanisms in pathogens: universal aneuploidy in Leishmania. Trends Parasitol. 2012, 28:370-376.
27. Farrer R.A., Henk D.A., Garner T.W.J., Balloux F., Woodhams D.C., Fisher M.C. Chromosomal Copy Number Variation, Selection and Uneven Rates of Recombination Reveal Cryptic Genome Diversity Linked to Pathogenicity. PLoS Genet. 2013, 9:e1003703.
28. Rehen S.K., Yung Y.C., McCreight M.P., Kaushal D., Yang A.H., Almeida B.S., Kingsbury M.A., Cabral K.M., McConnell M.J., Anliker B., Fontanoz M., Chun J. Constitutional aneuploidy in the normal human brain. J. Neurosci. Off. J. Soc. Neurosci. 2005, 25:2176-2180.
29. Duncan A.W., Hanlon Newell A.E., Smith L., Wilson E.M., Olson S.B., Thayer M.J., Strom S.C., Grompe M. Frequent aneuploidy among normal human hepatocytes. Gastroenterology 2012, 142:25-28.
30. Baker D.E., Harrison N.J., Maltby E., Smith K., Moore H.D., Shaw P.J., Heath P.R., Holden H., Andrews P.W. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 2007, 25:207-215.
31. Ben-David U., Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 2011, 11:268-277.
32. Lee A.J.X., Endesfelder D., Rowan A.J., Walther A., Birkbak N.J., Futreal P.A., Downward J., Szallasi Z., Tomlinson I.P.M., Howell M., Kschischo M., Swanton C. Chromosomal Instability Confers Intrinsic Multidrug Resistance. Cancer Res. 2011, 71:1858-1870.
33. Sionov E., Lee H., Chang Y.C., Kwon-Chung K.J. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PloS Pathog. 2010, 6:e1000848.
34. Duncan A.W., Hanlon Newell A.E., Bi W., Finegold M.J., Olson S.B., Beaudet A.L., Grompe M. Aneuploidy as a mechanism for stress-induced liver adaptation. J. Clin. Invest. 2012, 122:3307-3315.
35. Selmecki A., Forche A., Berman J. Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 2006, 313:367-370.
36. Yona A.H., Manor Y.S., Herbst R.H., Romano G.H., Mitchell A., Kupiec M., Pilpel Y., Dahan O. Chromosomal duplication is a transient evolutionary solution to stress. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:21010-21015.
37. Rancati G., Pavelka N., Fleharty B., Noll A., Trimble R., Walton K., Perera A., Staehling-Hampton K., Seidel C.W., Li R. Aneuploidy Underlies Rapid Adaptive Evolution of Yeast Cells Deprived of a Conserved Cytokinesis Motor. Cell 2008, 135:879-893.
38. Birchler J.A., Veitia R.A. Gene balance hypothesis: connecting issues of dosage sensitivity across biological disciplines. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:14746-14753.
39. Li Li B., Chang K.-H., Wang P.-R., Hirata Roli K., Papayannopoulou T., Russell David W. Trisomy Correction in Down Syndrome Induced Pluripotent Stem Cells. Cell Stem Cell 2012, 11:615-619.
40. Jiang J., Jing Y., Cost G.J., Chiang J.C., Kolpa H.J., Cotton A.M., Carone D.M., Carone B.R., Shivak D.A., Guschin D.Y., Pearl J.R., Rebar E.J., Byron M., Gregory P.D., Brown C.J., Urnov F.D., Hall L.L., Lawrence J.B. Translating dosage compensation to trisomy. Nature 2013, 21.
41. Waghmare S.K., Bruschi C.V. Differential chromosome control of ploidy in the yeast Saccharomyces cerevisiae. Yeast 2005, 22:625-639.
42. Reid R.J., Sunjevaric I., Voth W.P., Ciccone S., Du W., Olsen A.E., Stillman D.J., Rothstein R. Chromosome-scale genetic mapping using a set of 16 conditionally stable Saccharomyces cerevisiae chromosomes. Genetics 2008, 180:1799-1808.
43. Helentjaris T., Weber D.F., Wright S. Use of monosomics to map cloned DNA fragments in maize. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:6035-6039.
44. Malone J.H., Cho D.Y., Mattiuzzo N.R., Artieri C.G., Jiang L., Dale R.K., Smith H.E., McDaniel J., Munro S., Salit M., Andrews J., Przytycka T.M., Oliver B. Mediation of Drosophila autosomal dosage effects and compensation by network interactions. Genome Biol. 2012, 13:r28.
45. Parry E.M., Cox B.S. The tolerance of aneuploidy in yeast. Genet. Res. 1970, 16:333-340.
46. Kahlem P., Sultan M., Herwig R., Steinfath M., Balzereit D., Eppens B., Saran N.G., Pletcher M.T., South S.T., Stetten G., Lehrach H., Reeves R.H., Yaspo M.L. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res. 2004, 14:1258-1267.
47. Chikashige Y., Tsutsumi C., Okamasa K., Yamane M., Nakayama J.-i., Niwa O., Haraguchi T., Hiraoka Y. Gene Expression and Distribution of Swi6 in Partial Aneuploids of the Fission YeastSchizosaccharomyces pombe. Cell Struct. Funct. 2007, 32:149-161.
48. Vilardell M., Rasche A., Thormann A., Maschke-Dutz E., Perez-Jurado L.A., Lehrach H., Herwig R. Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes. BMC Genomics 2011, 12.
49. Stenberg P., Lundberg L.E., Johansson A.M., Ryden P., Svensson M.J., Larsson J. Buffering of segmental and chromosomal aneuploidies in Drosophila melanogaster. PLoS Genet. 2009, 5:e1000465.
50. Zhang Y., Malone J.H., Powell S.K., Periwal V., Spana E., Macalpine D.M., Oliver B. Expression in aneuploid Drosophila S2 cells. PLoS Biol. 2010, 8:e1000320.
51. Johansson A.M., Stenberg P., Bernhardsson C., Larsson J. Painting of fourth and chromosome-wide regulation of the 4th chromosome in Drosophila melanogaster. EMBO J. 2007, 26:2307-2316.
52. Johansson A.M., Stenberg P., Allgardsson A., Larsson J. POF regulates the expression of genes on the fourth chromosome in Drosophila melanogaster by binding to nascent RNA. Mol. Cell. Biol. 2012, 32:2121-2134.
53. Vicoso B., Bachtrog D. Reversal of an ancient sex chromosome to an autosome in Drosophila. Nature 2013, 499:332-335.
54. Tange Y., Kurabayashi A., Goto B., Hoe K.L., Kim D.U., Park H.O., Hayles J., Chikashige Y., Tsutumi C., Hiraoka Y., Yamao F., Nurse P., Niwa O. The CCR4-NOT complex is implicated in the viability of aneuploid yeasts. PLoS Genet. 2012, 8:e1002776.
55. Miller J.E., Reese J.C. Ccr4-Not complex: the control freak of eukaryotic cells. Crit. Rev. Biochem. Mol. Biol. 2012, 47:315-333.
56. Dimitrova L.N., Kuroha K., Tatematsu T., Inada T. Nascent Peptide-dependent Translation Arrest Leads to Not4p-mediated Protein Degradation by the Proteasome. J. Biol. Chem. 2009, 284:10343-10352.
57. Mersman D.P., Du H.-N., Fingerman I.M., South P.F., Briggs S.D. Polyubiquitination of the demethylase Jhd2 controls histone methylation and gene expression. Genes Dev. 2009, 23:951-962.
58. Torres E.M., Dephoure N., Panneerselvam A., Tucker C.M., Whittaker C.A., Gygi S.P., Dunham M.J., Amon A. Identification of aneuploidy-tolerating mutations. Cell 2010, 143:71-83.
59. Jansen R., Greenbaum D., Gerstein M. Relating whole-genome expression data with protein-protein interactions. Genome Res. 2002, 12:37-46.
60. Hwang C.S., Shemorry A., Varshavsky A. N-terminal acetylation of cellular proteins creates specific degradation signals. Science 2010, 327:973-977.
61. Shemorry A., Hwang C.S., Varshavsky A. Control of protein quality and stoichiometries by N-terminal acetylation and the N-end rule pathway. Mol. Cell 2013, 50:540-551.
62. Springer M., Weissman J.S., Kirschner M.W. A general lack of compensation for gene dosage in yeast. Mol. Syst. Biol. 2010, 6:368.
63. Geiger T., Cox J., Mann M. Proteomic changes resulting from gene copy number variations in cancer cells. PLoS Genet. 2010, 6:e1001090.
64. Gidalevitz T., Kikis E.A., Morimoto R.I. A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr. Opin. Struct. Biol. 2010, 20:23-32.
65. Balch W.E., Morimoto R.I., Dillin A., Kelly J.W. Adapting proteostasis for disease intervention. Science 2008, 319:916-919.
66. Tang Y.C., Williams B.R., Siegel J.J., Amon A. Identification of aneuploidy-selective antiproliferation compounds. Cell 2011, 144:499-512.
67. Oromendia A.B., Dodgson S.E., Amon A. Aneuploidy causes proteotoxic stress in yeast. Genes Dev. 2012, 26:2696-2708.
68. Hartl F.U., Bracher A., Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature 2011, 475:324-332.
69. Gidalevitz T., Prahlad V., Morimoto R.I. The stress of protein misfolding: from single cells to multicellular organisms. Cold Spring Harb. Perspect. Biol. 2011, 3.
70. Anckar J., Sistonen L. Regulation of HSF1 function in the heat stress response: implications in aging and disease. Ann. Rev. Biochem. 2011, 80:1089-1115.
71. Geiler-Samerotte K.A., Dion M.F., Budnik B.A., Wang S.M., Hartl D.L., Drummond D.A. Misfolded proteins impose a dosage-dependent fitness cost and trigger a cytosolic unfolded protein response in yeast. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:680-685.
72. Makhnevych T., Houry W.A. The role of Hsp90 in protein complex assembly. Biochim. Biophys. Acta 2012, 1823:674-682.
73. Caplan A.J., Mandal A.K., Theodoraki M.A. Molecular chaperones and protein kinase quality control. Trends Cell Biol. 2007, 17:87-92.
74. Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat. Rev. Mol. Cell Biol. 2005, 6:79-87.
75. Hershko A. The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle. Cell Death Differ. 2005, 12:1191-1197.
76. Borodovsky A., Kessler B.M., Casagrande R., Overkleeft H.S., Wilkinson K.D., Ploegh H.L. A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J. 2001, 20:5187-5196.
77. Guterman A., Glickman M.H. Complementary roles for Rpn11 and Ubp6 in deubiquitination and proteolysis by the proteasome. J. Biol. Chem. 2004, 279:1729-1738.
78. Lundberg L.E., Figueiredo M.L., Stenberg P., Larsson J. Buffering and proteolysis are induced by segmental monosomy in Drosophila melanogaster. Nucleic Acids Res. 2013, 40:5926-5937.
79. Peth A., Kukushkin N., Bosse M., Goldberg A.L. Ubiquitinated proteins activate the proteasomal ATPases by binding to Usp14 or Uch37 homologs. J. Biol. Chem. 2013, 288:7781-7790.
80. Pankiv S., Clausen T.H., Lamark T., Brech A., Bruun J.A., Outzen H., Overvatn A., Bjorkoy G., Johansen T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 2007, 282:24131-24145.
81. Wooten M.W., Geetha T., Babu J.R., Seibenhener M.L., Peng J., Cox N., Diaz-Meco M.T., Moscat J. Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins. J. Biol. Chem. 2008, 283:6783-6789.
82. Kuusisto E., Kauppinen T., Alafuzoff I. Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol. Appl. Neurobiol. 2008, 34:169-180.
83. Lamark T., Johansen T. Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int. J. Cell Biol. 2012, 2012:736905.
84. Verhoef L.G., Lindsten K., Masucci M.G., Dantuma N.P. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins. Hum. Mol. Genet. 2002, 11:2689-2700.
85. Stingele S., Stoehr G., Storchova Z. Activation of autophagy in cells with abnormal karyotype. Autophagy 2013, 9:246-248.
86. Ciocca D.R., Arrigo A.P., Calderwood S.K. Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update. Arch. Toxicol. 2013, 87:19-48.
87. Garcia-Carbonero R., Carnero A., Paz-Ares L. Inhibition of HSP90 molecular chaperones: moving into the clinic. Lancet Oncol. 2013, 14:e358-e369.
88. Choi A.M., Ryter S.W., Levine B. Autophagy in human health and disease. N. Engl. J. Med. 2013, 368:651-662.
89. Adams J. The proteasome: a suitable antineoplastic target. Nat. Rev. Cancer 2004, 4:349-360.